AI-mammography systems detect 1 in 5 breast cancer cases 6 years before diagnosis

• Three AI-based mammography systems were able to identify subtle signs of future breast cancer years before diagnosis, with elevated cancer prediction scores seen in those who later developed the disease.
• In the study, approximately 20% of breast cancer cases showed AI-detectable mammographic changes as early as 6 years before diagnosis.
• At 90% specificity, the AI systems flagged potential future cancers in up to 19.7% of women 6 years before diagnosis, 25.2% 4 years before diagnosis, and 39.3% 2 years before diagnosis.
• The findings suggest AI could support earlier breast cancer detection and help enable more personalized screening strategies by identifying females who may benefit from closer monitoring or earlier intervention.

Artificial intelligence (AI) is becoming an increasingly valuable tool in cancer detection, improving the speed, accuracy, and reliability of screening and diagnostic methods. In particular, AI-based models have substantially advanced medical imaging by enabling more efficient lesion and disease site identification, supporting earlier detection and more accurate diagnoses.

Advanced AI algorithms can analyze medical images, such as mammograms, to detect subtle changes that may be difficult to otherwise detect. By assisting with early diagnosis, AI has the potential to improve patient outcomes, reduce diagnostic errors, and support more personalized treatment plans.

Now, researchers suggest that 3 commercially available AI tools could help identify subtle mammographic changes years before breast cancer is diagnosed, potentially detecting early signs of breast cancer up to 6 years before a formal diagnosis.

Published in Radiology, the AI systems consistently assigned higher cancer risk scores to women who later developed breast cancer, while generating lower scores for those who remained cancer-free.

The findings add to a growing body of evidence suggesting that AI could play an increasingly important role in improving breast cancer screening and identifying cancers at an earlier, potentially more treatable stage.